PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Arud Centre for Addiction Medicine, Zurich, Switzerland.\', \'Institute of Primary Care, University and University Hospital of Zurich, Switzerland.\', \'Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Switzerland.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.4414/smw.2022.w30122Swiss Med Wkly. 2022;152:w30122
?:doi
?:hasPublicationType
?:journal
  • Swiss medical weekly
is ?:pmid of
?:pmid
?:pmid
  • 35019254
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.8
?:rankingScore_hIndex
  • 62
is ?:relation_isRelatedTo_publication of
?:title
  • High SARS-CoV-2 seroprevalence but no severe course of COVID-19 disease among people on opioid agonist treatment in Zurich: a cross-sectional study.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35019254>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35019254>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all